ABPI respond to proposals to change the Statutory Scheme

The Association of the British Pharmaceutical Industry (ABPI) has published an executive summary [1] of its consultation response to the government's proposed changes to the Statutory Scheme for branded medicines [2].In its response, the ABPI acknowledged and broadly supported the government’s intention to bri...

Related Keywords

United Kingdom ,British ,David Watson ,Association Of The British Pharmaceutical Industry ,British Pharmaceutical Industry ,Statutory Scheme ,Voluntary Scheme ,Pricing Access ,Voluntary Schemes ,Executive Director ,Patient Access ,